On Thursday, CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73.
This unique rating identifies technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the best stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if CVS Health stock can continue to show renewed price strength and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Is CVS Health Stock A Buy?
CVS Health stock is working on a cup without handle with a 67.80 entry. See if it can clear the breakout price in volume at least 40% above average.
While sales growth fell last quarter from 6% to 4%, EPS grew -44%, up from -51% in the previous report.
CVS Health stock earns the No. 9 rank among its peers in the Medical-Managed Care industry group. Alignment Healthcare, Astrana Health and Concentra Group are among the top 5 highly rated stocks within the group.
